One such mechanism, postulated by Hawkins et al. (2019), is that of oxytocin, a hormone whose intranasal administration has been shown to decrease the levels of psychotic symptomatology in patients with schizophrenia [33], and whose levels increase with the interaction of human beings with dogs [34]. The gene discussed is OXT; the disease is schizophrenia.